Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 07, 2009 3:50 PM

Elan Corporation, plc

Elan Corporation, plc - Click to view image in its original context
Elan Corporation, plc
Type: Company
Name: Elan Corporation, plc (Elan Corporation Plc, Elan Corporation plc)
Nationality: Ireland
Fact Sheet: Fact Sheet for Elan Corporation, plc
First Reported 16 hours ago - Updated 16 hours ago - 1 Documents
NEW YORK -(Dow Jones)- Biogen Idec Inc. (BIIB) amended the U.S. label of multiple sclerosis treatment Tysabri, sold with Elan Corp. PLC (ELN), on Friday to reflect that the risk of a rare brain infection rises with longer usage.The changes, which were ... [Nasdaq - 16 hours ago]
First Reported 11/02/2009 - Updated 11/03/2009 - 2 Documents (in Internet & IT)
LONDON--(BUSINESS WIRE)--The following amendment should be made to the 'Partial Repurchase' announcement released at 11:28am GMT yesterday November 2nd 2009.The Issuer in question should be ELAN LTD and not Elan Corp.All other details remain unchange ... [Business Wire UK - 11/03/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents (in Health)
William Weldon - Click to view image in its original context
William Weldon
Alexandra Frean, US Business CorrespondentJohnson & Johnson, the US healthcare giant, is cut up to 8,190 jobs from its worldwide workforce as part of a major restructuring designed to save up to $1.7 billion a year.The job cuts, representing between six ... [Times Online - 11/03/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents (in Biology)
NEW BRUNSWICK, N.J.-Amidst its year-long acquisition spree and poor third-quarter revenues, announced today that it may cut more than 8,000 jobs and set other restructuring moves in order to save up to $900 million next year. J&J said plans to simplify ... [Drug Discovery News - 11/03/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents
Johnson & Johnson - Click to view image in its original context
Johnson & Johnson
NEW YORK (Reuters) - Johnson & Johnson (JNJ.N) plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said ... [Reuters UK - 11/03/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents
Two weeks after (NYSE:JNJ) , which tugged stocks downward, the world's biggest healthcare company is . Those cuts include 7,000 to 8,000 layoffs, mostly overseas.J&J chief executive (pictured) said in a statement, 'These types of changes are difficult ... [TheDeal.com - 11/03/2009]
First Reported 11/02/2009 - Updated 11/02/2009 - 1 Documents
BNP Paribas SA - Click to view image in its original context
BNP Paribas SA
* FTSEurofirst 300 index down 2.1 percent on day, and month* Banks fall as U.S. mixed economic data weighs* Commodities slip as crude, metals prices retreatLONDON, Oct 30 - European shares fell sharply on Friday on mixed U.S. data and as traders booked ... [Alibaba.com - 11/02/2009]
First Reported 10/23/2009 - Updated 10/23/2009 - 7 Documents (in Biology)
WASHINGTON, Oct 23 (Reuters) - U.S. Food and Drug Administration spokeswoman Sandy Walsh on Friday said:* there have been 23 confirmed cases of progressive multifocal leukoencephalopathy (PML), a potentially fatal brain infection, in patientstreated with ... [FinanzNachrichten.de - 10/23/2009]
First Reported 10/14/2009 - Updated 10/14/2009 - 5 Documents (in Corporate Deals)
Elan Corporation, plc (NYSE:ELN) ("Elan") today announced the results as of the early tender date of the tender offer for the 7% Senior Fixed Rate Notes due 2011 (CUSIP No. 284138AC8) (the Notes) issued by its wholly-owned subsidiaries, Elan Finance public ... [News-Medical.Net - 10/14/2009]
First Reported 10/14/2009 - Updated 10/14/2009 - 5 Documents
BusinessWire - Zacks Equity Research highlights VimpelCom (NYSE: VIP) as the Bull of the Day and Rite Aid Corporation (NYSE: RAD) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Johnson & Johnson (NYSE: JNJ), Elan Pharmaceuticals ... [Forbes.com - 10/14/2009]
First Reported 10/19/2009 - Updated 10/20/2009 - 6 Documents
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDQ: BIIB) today announced multiple presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place October 23-28 in San Diego.The posters and presentations during ... [News-Medical.Net - 10/20/2009]
First Reported 10/21/2009 - Updated 10/21/2009 - 2 Documents
Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ELAN+CORP+PLC+++++++++++++For%3A+Oct+21/5033978.html for the full story. ... [Street Insider - 10/21/2009]

Quotes

...changes are difficult under any circumstances, and will have a very personal impact on people who have been dedicated to the mission of ," he said. "We recognize their contributions to the achievements of our business, and are committed to treating them fairly and with respect throughout this process." Nevertheless, J&J has been on a buying spree for most of 2009...
Elan Corporation plc ELN ( "Elan') today announced the expiration and final results of the tender offer for the 7¾% Senior Fixed Rate Notes due 2011 (CUSIP No. 284138AC8) (the “Notes”) issued by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. (the “Co-Issuers”). The tender offer expired on October 28, 2009, at 11:59 p.m., New York City time (the 'Expiration Date'). On October 14, 2009, the Co-Issuers made a payment in cash for all Notes tendered prior to 11:59 p.m., New York City time, on October 13, 2009 (the 'Early Tender Date'). As of the Early Tender Date, the Co-Issuers had received tenders in respect of $783.9 million aggregate principal amount of Notes, representing approximately 92.23% of the outstanding Notes, all of which were accepted for purchase. The holders of such Notes received total consideration of $1,019.38 per $1,000 of principal amount tendered. The total consideration included an early tender premium of $30.00 per $1,000 principal amount of Notes tendered. The total cash payment to purchase such Notes, including accrued and unpaid interest up to, but not including, the early payment date, was approximately $824.3 million."
...1m a year ago. Chief executive Kelly Martin said: The third quarter of 2009 proved to be a time of significant transformation for Elan. "Completion of the Johnson & Johnson transaction and the subsequent refinancing of our balance sheet provide strategic flexibility and financial stability for the company. 'We are now afforded the opportunity to focus on growing Tysabri and EDT businesses, advancing our bioneurology pipeline and investing in unique science while having fundamentally reduced business risk across the enterprise. Story provided by Business Financial Newswire"
Elan Corporation plc ELN ( "Elan') today announced the results as of the early tender date of the tender offer for the 7% Senior Fixed Rate Notes due 2011 (CUSIP No. 284138AC8) (the Notes) issued by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. (the Co-Issuers)."

More Content

All (277) | News (260) | Reports (0) | Blogs (13) | Audio/Video (0) | Fact Sheets (4)
sort by: Date | Relevance
Biogen Updates Tysabri Label To Reflect Risk Wi... [Nasdaq - 16 hours ago]
Written Requests Issued [FDA - 11/06/2009]
J&J to cut 7000 jobs [The Money Times - 11/05/2009]
J&J chief calls job cuts 'difficult' [TheDeal.com - 11/03/2009]
J&J to cut 6-7 percent of workforce in rest... [Exec Digital US - 11/03/2009]
J&J slashing workforce [Reuters UK - 11/03/2009]
J&J slashes    ... [MarketWatch - 11/03/2009]
J&J may cut more than 8,000 jobs [Drug Discovery News - 11/03/2009]
Johnson & Johnson to axe 8,190 global jobs [Times Online - 11/03/2009]
Johnson & Johnson to cut up to 8,200 jobs [MarketWatch - 11/03/2009]
Complimentary Sector & Company Analysis on ... [Yahoo! Canada - 11/03/2009]
E.L.A.N. Ld UK Regulatory Announcement: Partial... [Business Wire UK - 11/03/2009]
Taking a stake [Drug Discovery News - 11/03/2009]
October Overview: The Goblins Came Home to Roost [Seeking Alpha - 11/02/2009]
Elan Corporation PLC UK Regulatory Announcement... [Business Wire UK - 11/02/2009]
Europe stocks post first monthly drop... [Alibaba.com - 11/02/2009]
Loomis Group Health, Capella Advisors Form Stra... [Drugs.com - 11/01/2009]
Research and Markets: Allergan Inc.: PharmaVita... [Zibb - 10/30/2009]
Europe stocks post first monthly drop since June [FinanzNachrichten.de - 10/30/2009]
GE, WFC, PG, GT, LSI, ELN With Highest Daily Sh... [TMC Net - 10/30/2009]
Banks gaining ground on ISEQ [Breaking News.ie - 10/30/2009]
BRIEF-Elan Corp result of tender offer for note... [Forbes.com - 10/30/2009]
Elan: Expiration Of Tender Offer 7.75% Senior N... [Morningstar UK - 10/30/2009]
BRIEF-Elan Corp result of tender offer for note... [Interactive Investor International - 10/30/2009]
Elan Corporation Plc Announces Expiration of Te... [Business Wire via MSN Money - 10/29/2009]
Europe Regulators Report 4 PML Deaths On Tysabr... [Nasdaq - 10/29/2009]
UPDATE 1-EU agency reports 24th case of Tysabri... [Reuters UK - 10/29/2009]
Subset Data From Two Randomized Phase 3 Trials ... [Medical News Today - 10/29/2009]
GlaxoSmithKline Wins FDA Approval for Cancer Drug [Seeking Alpha - 10/28/2009]
Treatment with TYSABRI reduces the rate of hosp... [News-Medical.Net - 10/28/2009]
1 2 3 4 5 6 7 8 9
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Top 10 Analyst Upgrades, Downgrades, Initiation... [24/7 Wall St. - 10/29/2009]
These are this Thursday morning’s top 10 analyst upgrades, downgrades, and initiations we have seen in early research calls from Wall Street: ArcelorMittal (NYSE: ...
J&J lowers price of Elan stake [The Deal.com - 09/15/2009]
Irish drugmaker Elan Corp. plc has revised its agreement with healthcare giant Johnson & Johnson and will get $885 million for an 18.4% stake in the company -- $115 ...
J&J and Elan Cut Deal Price to Resolve Biog... [DealBook - 09/15/2009]
Johnson & Johnson has cut the amount it will pay for its 18.4 percent stake in Irish drugmaker Elan Corp by $115 million to $885 million, Elan confirmed Monday. ...
The Morning’s News: Word Up! Microsoft Wins a S... [WSJ.com: Law Blog - 09/04/2009]
A few items we’ve got to get to, LBers, this morning, just to make sure you’re well-informed before you put your head down and churn out a few last billables before ...
Deal Stocks: AIG, BIIB, CS, ELN, HBC, ING, JNJ,... [The Deal.com - 09/04/2009]
A look at the news moving deal-related stocks on Friday including HSBC, Prudential, Biogen, and Elan Corp. ...
1 2 3

  •  
  •  
  •